CURIA^TM is unbiased in sourcing information, taking information from reliable official sources.

Cancer treatments approved for countries in which CURIA^TM is available are in the app, including on and off-label therapies.

Experts available in the app are selected according to a broad range of criteria including time in practice, participation in scientific research, and institution type. The CURIA^TM app includes oncology experts for all indications available in the app, and for all countries for which CURIA^TM is available.

All clinical trials in phase 2 and 3 are available in the app, updated in near real-time. Some phase 1 trials are included when they are inherently combined with phase 2.